These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 33791)
1. [Relations between the levels of neuroleptics and the doses, the therapeutic effects and the side effects]. Davy JP; Moulin M; Andersson JC; Halbecq JJ; Morel P; Poilpre E Encephale; 1978; 4(4):293-321. PubMed ID: 33791 [TBL] [Abstract][Full Text] [Related]
2. Blood levels of neuroleptics: state of the art. Simpson GM; Yadalam K J Clin Psychiatry; 1985 May; 46(5 Pt 2):22-8. PubMed ID: 2859277 [TBL] [Abstract][Full Text] [Related]
3. Plasma level monitoring of antipsychotic drugs. Cooper TB Clin Pharmacokinet; 1978; 3(1):14-38. PubMed ID: 25154 [TBL] [Abstract][Full Text] [Related]
4. Neuroleptic plasma levels. Van Putten T; Marder SR; Wirshing WC; Aravagiri M; Chabert N Schizophr Bull; 1991; 17(2):197-216. PubMed ID: 1679251 [TBL] [Abstract][Full Text] [Related]
6. Influence of the antiparkinsonian drugs on the plasma level of neuroleptics. Gautier J; Jus A; Villeneuve A; Jus K; Pires P; Villeneuve R Biol Psychiatry; 1977 Jun; 12(3):389-99. PubMed ID: 871490 [TBL] [Abstract][Full Text] [Related]
7. Quantitation of Haloperidol, Fluphenazine, Perphenazine, and Thiothixene in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Slawson MH; Johnson-Davis KL Methods Mol Biol; 2016; 1383():49-57. PubMed ID: 26660173 [TBL] [Abstract][Full Text] [Related]
8. The strategy and value of neuroleptic drug monitoring. Curry SH J Clin Psychopharmacol; 1985 Oct; 5(5):263-71. PubMed ID: 2864358 [TBL] [Abstract][Full Text] [Related]
9. Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients. Tune LE; Creese I; DePaulo JR; Slavney PR; Snyder SH J Nerv Ment Dis; 1981 Jan; 169(1):60-3. PubMed ID: 6108981 [TBL] [Abstract][Full Text] [Related]
10. Penfluridol and thiothixene. Dosage, plasma levels and changes in psychopathology. Jacobsson L; von Knorring L; Mattsson B; Mjörndal T; Oreland L; Perris C; Rapp W; Edenius B; Kettner B; Magnusson KE; Villemoes P Int Pharmacopsychiatry; 1976; 11(4):206-14. PubMed ID: 795779 [TBL] [Abstract][Full Text] [Related]
11. [Correlation between plasma concentration and clinical effect of neuroleptics and antidepressants]. Modestin J; Petrin A Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):11-21. PubMed ID: 2561 [TBL] [Abstract][Full Text] [Related]
12. Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations. Greendyke RM; Kanter DR J Clin Psychopharmacol; 1987 Jun; 7(3):178-82. PubMed ID: 3597804 [TBL] [Abstract][Full Text] [Related]
13. Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects. Dahl SG Ther Drug Monit; 1982; 4(1):33-40. PubMed ID: 6122292 [TBL] [Abstract][Full Text] [Related]
15. Blood levels of neuroleptic drugs in nonresponding chronic schizophrenic patients. Smith RC; Crayton J; Dekirmenjian H; Klass D; Davis JM Arch Gen Psychiatry; 1979 May; 36(5):579-84. PubMed ID: 35115 [TBL] [Abstract][Full Text] [Related]
16. A radioreceptor assay for neuroleptic drugs in plasma. Lader SR J Immunoassay; 1980; 1(1):57-75. PubMed ID: 6112242 [TBL] [Abstract][Full Text] [Related]
17. Receptor techniques in the study of plasma levels of neuroleptics and antidepressant drugs. Smith RC; Vroulis G; Misra CH; Schoolar J; DeJohn C; Korivi P; Leelavathi DE; Arzu D Commun Psychopharmacol; 1980; 4(6):451-65. PubMed ID: 7297052 [No Abstract] [Full Text] [Related]
18. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia. Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346 [TBL] [Abstract][Full Text] [Related]